India, Sept. 18 -- Natco Pharma Ltd on Thursday said the US Food and Drug Administration (US FDA) has issued an Establishment Inspection Report (EIR) for its pharma division at Kothur, Hyderabad.
The inspection has been classified as "Voluntary Action Indicated" (VAI), the company informed in a filing to the exchanges.
Published by HT Digital Content Services with permission from Dion Global Solutions Limited....